Currently, the US Drug Enforcement Administration (DEA) classifies copyright being a Program II drug, recognizing its high possible for abuse but nonetheless allowing its confined use for health-related reasons. Having said that, current pharmacoepidemiological trends suggest that copyright could quickly achieve the point the place, in practical te